Rob Waugh, the tech correspondent for Daily Mail, asked two leading chatbots -- Google's Bard and Amazon's Claude -- for their 2024 predictions. He opted for the pair because they use live information, unlike ChatGPT and Microsoft's Bing, which rely on older data.
Here are three of its predictions.
AI Systems Could Start To Reason By Themselves
Claude.ai predicted the first AI models might exhibit "artificial general intelligence" (AGI) symptoms. AGI is a hypothetical intelligent agent that is expected to fundamentally alter human society by being able to perform any intellectual work that a human can.
"Groups like DeepMind, OpenAI, Google Brain, and Anthropic are pushing towards this goal of AGI. While we likely won't fully crack general intelligence by 2024, we might see demos of systems that start displaying more expansive reasoning, creativity, and decision-making abilities," Waugh wrote.
Claude's parent firm, Anthropic, was established by ChatGPT makers, who were once members of OpenAI and are supported by Google and Amazon. According to them, they witnessed AI algorithms exceeding human performance in specialized tasks like object recognition, language processing, and game playing in recent years.
"Techniques like deep learning and neural networks running on powerful computing infrastructure have driven these leaps forward. Major investments from big tech companies and startups suggest the pace of innovation isn't slowing anytime soon," the AI chatbot said.
According to Claude.ai, unpredictable system behavior and job automation surpassing workers' capacity for adaptation are two potential issues with AI.
Biotechnology To Upgrade the Human Race
Bard projected that biotechnology advancements that "upgrade" humanity may occur around 2024. According to Google's AI chatbot, this might involve advancements in "Brain-Computer Interfaces," or connecting computers and human brains.
In a study done this year by Foresight Factory, over one-third of consumers said they would be content to have a chip like that implanted so they could interact with computers more readily. Developments in biocompatible materials and robotics may result in prosthetic limbs that return motor function close to normal or perhaps exceed human limits in terms of strength and dexterity.
According to Bard, exoskeletons might improve physical prowess for heavy lifting, military use, or helping older people.
Brain-computer interfaces (BCIs) have the potential to facilitate direct brain-to-computer communication. This could lead to the control of external equipment, virtual environments, and prostheses. Potential uses include brain-to-brain communication, improved productivity and creativity, and communication for paralyzed people.
Realistic touch sensation-generating devices have the potential to transform virtual reality and other immersive experiences, improving gaming, entertainment, and medical education.
RELATED ARTICLE : Elon Musk is Looking for a Neuralink Clinical Trial Director; Does It Mean It Has A Toxic Work Environment?
Personalized Medicine
According to Bard, new developments in customized medicine could be fueled by AI in the upcoming year. Precision medicine, another name for personalized medicine, seeks to customize preventative measures and therapeutic approaches to each patient's genetic, environmental, and behavioral characteristics.
AI is becoming a game-changer in this pursuit, driving innovations across various healthcare domains. Artificial intelligence (AI) can mine Electronic Health Records (EHRs) to find hidden patterns and correlations between symptoms, drugs, and results. This can result in more precise diagnosis and individualized therapy recommendations.
"AI can analyze patient data and predict how they might respond to different treatments, helping doctors choose the most effective and least harmful options for each individual," Bard said.
RELATED ARTICLE : Elon Musk is Looking for a Neuralink Clinical Trial Director; Does It Mean It Has A Toxic Work Environment?
Check out more news and information on TECH & INNOVATION in Science Times.